Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | HBB | P68871 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | NQO1 | P15559 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | NQO2 | P16083 | 5/20 | 0.33 |
| ▸ | RAB9A | P51151 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15066852 | 0.94 | CYP2A6 (0.48) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL28254116 | 0.83 | ALDH1A1 (0.47) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL2352248 | 0.82 | CYP2A6 (0.43) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL6746638 | 0.82 | CYP2A6 (0.43) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL6749563 | 0.79 | CYP2A6 (0.37) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL9804773 | 0.79 | ALDH1A1 (0.44) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL22960091 | 0.79 | ALDH1A1 (0.44) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL15066858 | 0.78 | CYP2A6 (0.48) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL6748687 | 0.76 | ALDH1A1 (0.44) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 | |
| SCHEMBL29895592 | 0.75 | CYP2A6 (0.50) | CYP2A6CYP1A2ALDH1A1TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6696588-B2 | OXIDATION POTENTIAL OF .3-1.5 V ON THE BASIS OF A STANDARD HYDROGEN ELECTRODE, ALKOXY AND AROMATIC AMINE DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-02-24 | — | — | US | disclosed |
| EP-0861845-B1 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL CO (JP) | 2003-05-28 | — | — | EP | disclosed |
| US-20020115877-A1 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-08-22 | — | — | US | disclosed |
| US-6369258-B1 | SILICON COMPOUND WITH OXIDATION POTENTIAL ON HYDROGEN ELECTRODE POTENTIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-09 | — | — | US | disclosed |
| EP-0861845-A2 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115877-A1 | Silicon-containing compound and organic electroluminescence device using the same | EPCAM, PIEZO1, OR10J3 | CYP2A6 4100/4885CYP1A2 2466/4885ALDH1A1 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.